Clinical Trial Update: Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating capecitabine (Xeloda) with radiation for rectosigmoid carcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: James A. Haley Veterans Administration Hospital | Conditions: Colorectal Cancer | Phase 4 | Status: TERMINATED